Discover investment opportunities in Top 10 Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 10 Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 10 Stocks Under $1 using our Smart AI Filter.
8 stocks found for "Top 10 Stocks Under $1"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.18 | ±100.0% | -1.1 | 0.00% | |||
0.76 | ±100.0% | -0.1 | 0.00% | |||
1.01 | ±72.3% | -3.1 | 0.00% | |||
0.15 | ±100.0% | -0.2 | 0.00% | |||
0.65 | ±93.4% | -1.0 | 0.00% | |||
0.64 | ±100.0% | -0.4 | 0.00% | |||
1.11 | ±100.0% | — | 0.00% | |||
0.86 | ±55.0% | 41.8 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What are the potential growth opportunities for KXIN?
A: Investors might find KXIN interesting due to its involvement in China's growing electric vehicle market. Demand in China for EVs is increasing due to environmental policies and consumer preferences. It's essential to evaluate KXIN's competitive position and execution strategy.
Q: Are there any dividend considerations when investing in VTAK?
A: VTAK, like many small-cap and penny stocks, typically doesn't offer dividends. Investors should check the latest financial reports or announcements from the company to confirm any dividend policies.
Q: What sector does NUWE belong to and what are its potential risks?
A: NUWE operates in the biotech sector, which inherently faces high volatility due to regulatory risks and the success of clinical trials. Investors should consider these factors along with company-specific developments.
Q: How has VXRT historically performed during economic downturns?
A: VXRT is a biotech firm, which can be a volatile sector. Historically, biotech stocks have mixed performance during downturns, often driven by specific news, such as drug approvals, rather than broader economic factors.
Q: Why might some investors consider ONCY a speculative buy?
A: ONCY operates in the biotech industry, known for long development timelines and breakthrough-dependent valuations. ONCY’s future largely depends on successful clinical trials, making it speculative for risk-tolerant investors.
Q: What is the technological focus of HCTI and how does it impact its stock appeal?
A: HCTI is involved in the clean technology sector, specifically focused on environmentally friendly innovations. This aligns with the growing ESG investment trend, potentially appealing to investors prioritizing sustainability.
Oncolytics Biotech (ONCY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Read moreDiscover why Zacks rates Healthcare Triangle as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore HCTI's heavy reliance on top clients amid liquidity issues and ongoing losses.
Read more